Facebook
Twitter
LinkedIn
Forward
Evolution of the Standards of Care in Atopic Dermatitis
Tuesday, February 18, 2025 at 2-3pm ET
Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Program Description
Treatment objectives are dynamic, changing with our growing comprehension of a disease and the emergence of potent therapies that enhance care standards. Advances in atopic dermatitis (AD) are elevating these care standards and allowing more patients to attain higher response levels, hence fine-tuning treatment objectives over time. The standard of care and refinement of treatment objectives continue to be enhanced by advancements in AD treatment. The benefits of achieving high treatment targets are now strong enough for medical guidelines to advocate for appropriate use of advanced therapies for AD. In budget constrained environments, payers need to understand how innovations are driving demand for novel mechanisms of action.
Learning Objectives
- Examine the evolution of goal-oriented therapy and how it informs treatment guidelines to enhance care standards in AD.
- Understand the benefits to payers and patients by achieving treatment targets for AD disease activity.
- Describe the clinical rationale for early use of advanced therapies in AD.
- List the ways in which payers can support treat-to-target strategies to improve patient outcomes.
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
Sponsored by:
For individuals from the media/press interested in attending, please email media@amcp.org.
Speaker:
Jonathan Silverberg, MD, PhD, MPH
Associate Professor of Dermatology
Director of Clinical Research and Contact Dermatitis
George Washington University of Medicine and Health Sciences
Jonathan Silverberg is a Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC. He is the Director of Clinical Research and Contact Dermatitis.
Dr. Silverberg completed his undergraduate and medical school training as a part of the highly selective dual B.A./M.D. program at State University of New York Downstate Medical Center, in Brooklyn. Dr. Silverberg also received his doctorate in neuroimmunology and Master of Public Health degree in biostatistics and epidemiology from the State University of New York Downstate Medical Center where he also completed his internship in internal medicine. He completed his residency training in dermatology at St. Luke’s-Roosevelt Hospital Center and Beth Israel Medical Centers in New York, NY and served as Chief Resident during his final year.
Dr. Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. He has extensive experience in the advanced management of atopic dermatitis, contact dermatitis, hand eczema, chronic itch, psoriasis, hidradenitis and many other chronic inflammatory skin disorders. He is also a national expert in allergy patch testing, phototesting and photopatch testing.
Dr. Silverberg’s research interests include the epidemiology of chronic and infectious diseases. He has published extensively on the epidemiology of chronic inflammatory skin diseases such as eczema, psoriasis and autoimmune blistering disorders as well infections such as COVID-19, measles, shingles, cellulitis and other skin and serious infections. Dr. Silverberg has also made major contributions to health services research, patient-reported outcome development, understanding comorbidities and burden of itch and inflammatory skin disease, advancing evidence-based dermatology, drug development, and clinical trial design. His publications include more than 700 peer-reviewed articles, and 1000 abstracts and book chapters. He is also the author of the Clinical Management of Atopic Dermatitis handbook (second edition published 2022).
Dr. Silverberg has also been a local, national and/or international principal investigator for numerous clinical trials for novel treatments in atopic dermatitis and other inflammatory disorders. He was recognized with several honors, including Top Doctor in Washington in 2020 and 2021, Young Leadership Award from the American Dermatological Association in 2017, Teacher of the Year Award in the department of dermatology in 2015, Outstanding Teacher’s Award from the Feinberg School of Medicine in 2016, 2017 and 2018, and the inaugural Rajka Award from the International Society for Atopic Dermatitis in 2014. He is an associate editor for the Journal of the American Academy of Dermatology, British Journal of Dermatology, Dermatitis, Archives of Dermatological Research and Current Dermatology Reports. Dr. Silverberg is a member of the International Eczema Council, North American Contact Dermatitis Group the American Society of Contact Dermatitis.
Dr. Silverberg is also the chair of the annual Revolutionizing Atopic Dermatitis global multidisciplinary conference, co-chair of the Revolutionizing Vitiligo and Revolutionizing Alopecia Areata global conferences, and Director of the Foundation for Dermatology Education.
Price
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.